338 related articles for article (PubMed ID: 33027633)
1. Structure-function correlation and personalized 3D printed tablets using a quality by design (QbD) approach.
Zhang J; Thakkar R; Zhang Y; Maniruzzaman M
Int J Pharm; 2020 Nov; 590():119945. PubMed ID: 33027633
[TBL] [Abstract][Full Text] [Related]
2. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
3. 3D printing of pharmaceutical oral solid dosage forms by fused deposition: The enhancement of printability using plasticised HPMCAS.
Oladeji S; Mohylyuk V; Jones DS; Andrews GP
Int J Pharm; 2022 Mar; 616():121553. PubMed ID: 35131354
[TBL] [Abstract][Full Text] [Related]
4. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
5. Tailoring amlodipine release from 3D printed tablets: Influence of infill patterns and wall thickness.
Obeid S; Madžarević M; Ibrić S
Int J Pharm; 2021 Dec; 610():121261. PubMed ID: 34742830
[TBL] [Abstract][Full Text] [Related]
6. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
Than YM; Titapiwatanakun V
Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
[TBL] [Abstract][Full Text] [Related]
7. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
8. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
9. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
Chung S; Zhang P; Repka MA
Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
[TBL] [Abstract][Full Text] [Related]
11. Fabrication of bilayer tablets using hot melt extrusion-based dual-nozzle fused deposition modeling 3D printing.
Zhang P; Xu P; Chung S; Bandari S; Repka MA
Int J Pharm; 2022 Aug; 624():121972. PubMed ID: 35787460
[TBL] [Abstract][Full Text] [Related]
12. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
[TBL] [Abstract][Full Text] [Related]
13. Multiple variable effects in the customisation of fused deposition modelling 3D-printed medicines: A design of experiments (DoE) approach.
Dos Santos J; Deon M; da Silva GS; Beck RCR
Int J Pharm; 2021 Mar; 597():120331. PubMed ID: 33540012
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of hot-melt extruded polycaprolactone-based filaments intended for 3D-printing of tablets.
Viidik L; Vesala J; Laitinen R; Korhonen O; Ketolainen J; Aruväli J; Kirsimäe K; Kogermann K; Heinämäki J; Laidmäe I; Ervasti T
Eur J Pharm Sci; 2021 Mar; 158():105619. PubMed ID: 33115676
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug release from diazepam FDM printed tablets using deep learning approach: Influence of process parameters and tablet surface/volume ratio.
Obeid S; Madžarević M; Krkobabić M; Ibrić S
Int J Pharm; 2021 May; 601():120507. PubMed ID: 33766640
[TBL] [Abstract][Full Text] [Related]
16. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
[TBL] [Abstract][Full Text] [Related]
17. Novel On-Demand 3-Dimensional (3-D) Printed Tablets Using Fill Density as an Effective Release-Controlling Tool.
Thakkar R; Pillai AR; Zhang J; Zhang Y; Kulkarni V; Maniruzzaman M
Polymers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825229
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the Fused Deposition Modeling Additive Manufacturing I: Influence of Process Temperature on the Quality and Crystallinity of the Dosage Forms.
Zhang J; Thakkar R; Kulkarni VR; Zhang Y; Lu A; Maniruzzaman M
AAPS PharmSciTech; 2021 Oct; 22(8):258. PubMed ID: 34697652
[TBL] [Abstract][Full Text] [Related]
19. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
20. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
